MD Stem Cells is the sponsor of Institutional Review Board (IRB) approved, National Institutes of Health (NIH) registered studies using autologous (from the same patient) Bone Marrow Derived Stem Cells (BMSC). Current studies encompass Ophthalmology, Neurology and Spinal Cord Injury/ Paraplegia. For detailed information please visit our website www.mdstemcells.com MD Stem Cells publishes extensively in peer-reviewed, high quality medical and scientific publications. MD Stem Cells provides the only available, proven treatment using BMSC for Non-arteritic ischemic optic neuropathy (NAION) also called a stroke of the optic nerve. We provide the only available, proven treatment for Retinitis Pigmentosa (RP). Both have proven findings that are statistically significant. Please see www.mdstemcells.com for details.
Looking for a particular MD Stem Cells employee's phone or email?
MD Stem Cells Questions
The MD Stem Cells annual revenue was $1 million in 2026.
Steven Levy is the Chairman of MD Stem Cells.
1 people are employed at MD Stem Cells.
MD Stem Cells is based in Westport, Connecticut.
The NAICS codes for MD Stem Cells are [621, 62111, 62, 6211, 621111].
The SIC codes for MD Stem Cells are [80, 801].
Top MD Stem Cells Employees
-
Steven Levy
Chairman at MD Stem Cells
Bridgeport, CT, US1
Related Companies
